Alvotech - Warrant — Cash Flow (NASDAQ:ALVOW) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -312.39 M-312.19 M-236.84 M-50.2 M — Cash from investing activities -63.54 M-46.34 M-18.87 M-104.22 M — Cash from financing activities 424.91 M301.32 M297.31 M270.83 M — Free cash flow -312.39 M-312.19 M-236.84 M-50.2 M —

News

AbbVie: Strong Q2 And New Catalysts Keep Me Bullish (NYSE:ABBV)

I Was Wrong About Johnson & Johnson: Upgrading To Hold (Rating Upgrade) (NYSE:JNJ)

Johnson & Johnson: Why I See Downside Ahead (NYSE:JNJ)

Royce Smaller-Companies Growth Fund FY 2025: What Worked… And What Didn’t

Alvotech: Why FDA Delays Don't Break The Bull Case (NASDAQ:ALVO)

Teva Pharmaceuticals: Why It’s Time To Cash Out (Downgrade) (NYSE:TEVA)

Alvotech: Initiating With Hold Rating On FDA CRL AVT05 And Reduced EBITDA Guidance (ALVO)

Johnson & Johnson Q3 Earnings Surprise, Icotrokinra Shines Again (NYSE:JNJ)

My Top 5 Biotech Stocks Big Pharma Could Buy Next

Alvotech (ALVO) Presents at Morgan Stanley 23rd Annual Global

Alvotech 2025 Q2 - Results - Earnings Call Presentation (NASDAQ:ALVO)

Alvotech (ALVO) Q2 2025 Earnings Call Transcript